By Dave Sebastian

Eli Lilly & Co. and Amgen Inc. said they are collaborating on making Lilly's potential Covid-19 antibody therapies, in an effort to boost supply if the treatment is approved.

The two companies expect to produce millions of doses next year, said Daniel Skovronsky, Lilly's chief scientific officer and president of Lilly Research Laboratories.

Write to Dave Sebastian at dave.sebastian@wsj.com

(END) Dow Jones Newswires

September 17, 2020 06:55 ET (10:55 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Eli Lilly Charts.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Eli Lilly Charts.